institutional
LI
NASDAQ · LIVN
LivaNova PLC
Healthcare · Medical - Devices
$78.01
Up+$0.22 (+0.28%)
Updated Sep 20, 2026, 6:55 PM
SID Score
5.5/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 3.49B
- P/E ratio
- -16.05
- Dividend yield
- 0.00%
- 52-week range
- $48.82 – $85.76
- Volume
- 1.38M
- Avg. volume
- 568.98K
Price performance
LIVN price history
1M range · 19 trading sessions · Daily adjusted prices
LIVN closed at $78.01 after 19 trading sessions, down 0.32% for the selected period.
- Last close
- $78.01
- Period change
- -0.32%
- Period low
- $77.79
- Period high
- $82.40
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | $77.34 | $78.44 | $76.78 | $78.01 | 1.38M |
| Sep 17, 2026 | $79.23 | $79.23 | $77.51 | $77.79 | 627.28K |
| Sep 16, 2026 | $79.56 | $80.63 | $77.69 | $78.51 | 693.56K |
| Sep 15, 2026 | $80.19 | $80.2379 | $79.13 | $79.47 | 587.23K |
| Sep 14, 2026 | $78.70 | $80.77 | $78.30 | $80.63 | 553.53K |
| Sep 11, 2026 | $79.22 | $79.27 | $77.15 | $78.18 | 552.42K |
| Sep 10, 2026 | $78.11 | $78.88 | $77.37 | $78.18 | 426.01K |
| Sep 9, 2026 | $80.22 | $80.37 | $78.105 | $78.93 | 674.36K |
| Sep 8, 2026 | $81.44 | $81.83 | $80.155 | $80.70 | 472.96K |
| Sep 4, 2026 | $80.67 | $82.22 | $80.39 | $81.92 | 334.17K |
| Sep 3, 2026 | $83.50 | $83.52 | $80.805 | $81.20 | 694.08K |
| Sep 2, 2026 | $80.16 | $83.315 | $80.16 | $82.40 | 769.66K |
| Sep 1, 2026 | $79.57 | $80.625 | $78.4935 | $80.16 | 585.41K |
| Aug 31, 2026 | $79.86 | $80.15 | $77.28 | $79.81 | 593.72K |
| Aug 28, 2026 | $80.10 | $80.765 | $79.425 | $80.32 | 465.95K |
| Aug 27, 2026 | $79.34 | $80.27 | $78.96 | $80.03 | 611.28K |
| Aug 26, 2026 | $79.83 | $80.03 | $77.63 | $79.97 | 733.43K |
| Aug 25, 2026 | $78.73 | $79.59 | $77.90 | $79.41 | 562.92K |
| Aug 24, 2026 | $78.65 | $80.00 | $78.00 | $78.26 | 823.21K |
Latest LIVN news
The latest Smart Investors Daily articles mentioning LIVN.
Stock researchResearch & News · SEC Filings
Loading stock research…